(Q44217072)

30 November 2017

title

Placebo and Analgesic Nitrous Oxide for Treatment of the Alcohol Withdrawal State (English)

1 reference

https://api.crossref.org/works/10.1192/BJP.159.5.672

16 November 2022

author name string

M. A. Gillman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1756344

16 November 2022

F. J. Lichtigfeld

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1756344

16 November 2022

language of work or name

English

0 references

publication date

1 November 1991

1 reference

full work available at URL

30 November 2017

https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S0007125000031056

1 reference

https://api.crossref.org/works/10.1192/BJP.159.5.672

British Journal of Psychiatry

16 November 2022

published in

1 reference

30 November 2017

volume

159

1 reference

30 November 2017

page(s)

672-675

1 reference

30 November 2017

cites work

Treatment of alcoholism

2

1 reference

https://api.crossref.org/works/10.1192/BJP.159.5.672

Analgesic nitrous oxide for alcohol withdrawal is better than placebo.

16 November 2022

3

1 reference

https://api.crossref.org/works/10.1192/BJP.159.5.672

Analgesic (sub anesthetic) nitrous oxide interacts with the endogenous opioid system: a review of the evidence

16 November 2022

4

1 reference

https://api.crossref.org/works/10.1192/BJP.159.5.672

Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome.

16 November 2022

5

1 reference

https://api.crossref.org/works/10.1192/BJP.159.5.672

Haematological changes caused by nitrous oxide. Cause for concern?

16 November 2022

7

1 reference

https://api.crossref.org/works/10.1192/BJP.159.5.672

Analgesic nitrous oxide for alcohol withdrawal: a critical appraisal after 10 years' use

16 November 2022

8

1 reference

https://api.crossref.org/works/10.1192/BJP.159.5.672

Central Deficiency of β-Endorphin in Alcohol Addicts*

16 November 2022

9

1 reference

https://api.crossref.org/works/10.1192/BJP.159.5.672

The effect of placebo in the alcohol withdrawal state.

16 November 2022

11

1 reference

https://api.crossref.org/works/10.1192/BJP.159.5.672

Non-drug treatment of alcohol withdrawal

16 November 2022

13

1 reference

https://api.crossref.org/works/10.1192/BJP.159.5.672

Alterations in β-adrenergic receptor binding during ethanol withdrawal

16 November 2022

16

1 reference

https://api.crossref.org/works/10.1192/BJP.159.5.672

Minimal sedation required with nitrous oxide-oxygen treatment of the alcohol withdrawal state.

16 November 2022

18

1 reference

https://api.crossref.org/works/10.1192/BJP.159.5.672

The efficacy of atenolol in the outpatient management of the alcohol withdrawal syndrome. Results of a randomized clinical trial

16 November 2022

19

1 reference

https://api.crossref.org/works/10.1192/BJP.159.5.672

The role of hypomagnesemia and respiratory alkalosis in the genesis of alcohol-withdrawal symptoms

16 November 2022

25

1 reference

https://api.crossref.org/works/10.1192/BJP.159.5.672

The treatment of alcohol withdrawal

16 November 2022

27

1 reference

https://api.crossref.org/works/10.1192/BJP.159.5.672

The initial management of alcoholism using oxygen and nitrous oxide: a transcultural study

16 November 2022

28

1 reference

https://api.crossref.org/works/10.1192/BJP.159.5.672

Analgesic nitrous oxide in neuropsychiatry: past, present and future

16 November 2022

29

1 reference

https://api.crossref.org/works/10.1192/BJP.159.5.672

Diazepam loading: simplified treatment of alcohol withdrawal.

16 November 2022

30

1 reference

https://api.crossref.org/works/10.1192/BJP.159.5.672

16 November 2022

Identifiers

1 reference

30 November 2017

1 reference